ASAN FOUNDATION
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Bioequivalence Study of Anastrozole 1 mg Tablet
- Conditions
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2010-04-16
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01105299
Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis
- Conditions
- Interventions
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 132
- Registration Number
- NCT01104311
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungnam, Korea, Republic of
🇰🇷Yeungnam University Hospital, Daegu, Korea, Republic of
🇰🇷Eulji University Hospital, Daejon, Korea, Republic of
Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia
- Conditions
- Interventions
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2010-03-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 178
- Registration Number
- NCT01096212
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Sanggye-Paik Hospital, Seoul, Korea, Republic of
Isoniazid (INH) Treatment Based on ELISPOT Assay
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 831
- Registration Number
- NCT01087190
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
- Conditions
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT01068990
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 39
- Registration Number
- NCT01050036
- Locations
- 🇰🇷
Wonkwang University Hospital, Iksan, Chollabuk-do, Korea, Republic of
🇰🇷Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, Korea, Republic of
🇰🇷Kosin University, Gospel Hospital, Busan, Korea, Republic of
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
- Conditions
- Interventions
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01049620
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Venous Thromboembolism in Advanced Gastric Cancer Patients
- Conditions
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 259
- Registration Number
- NCT01047618
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP
- Conditions
- Interventions
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01045538
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01037764
- Locations
- 🇰🇷
Inje University Haeundae Paik Hospital, Pusan, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of